Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net (loss) income	$ (28,599,303)	$ 9,265,598
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization		13,100
Accretion of marketable securities premium		(86,774)
Amortization of right-of-use assets	101,786	118,487
Stock-based compensation expense	4,014,650	7,739,704
Non-cash interest expense associated with the sale of future royalties	4,594,985
Changes in operating assets and liabilities
Prepaid expenses and other current assets	232,813	(1,191,811)
Capitalized software	(51,080)
Other noncurrent assets	14,808
Accounts payable	204,895	(1,615,419)
Accrued expenses and other current liabilities	(171,158)	396,747
Operating lease liabilities, current	(111,229)	(15,945)
Deferred revenue		(41,175,600)
Operating lease liabilities, noncurrent		(111,229)
Net cash used in operating activities	(19,768,833)	(26,663,142)
Cash flows from investing activities:
Proceeds from the maturity and redemption of marketable securities		28,400,000
Purchase of marketable securities		(3,871,706)
Net cash provided by investing activities		24,528,294
Cash flows from financing activities:
Proceeds from the sale of future royalties	60,000,000
Proceeds from sales of common stock in public offering		12,550,069
Fees paid in connection with public offering		(455,666)
Proceeds from exercise of stock options		1,143,655
Net cash provided by financing activities	60,000,000	13,238,058
Net increase in cash, cash equivalents and restricted cash	40,231,167	11,103,210
Cash, cash equivalents and restricted cash
Beginning of period	25,456,952	21,512,623
End of period	65,688,119	32,615,833
Reconciliation of the Condensed Consolidated Statements of Cash Flows to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	65,588,119	32,515,833
Restricted cash	100,000	100,000
Total cash, cash equivalents and restricted cash	$ 65,688,119	$ 32,615,833